Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Dampening insulin signaling by an NLRP3 'meta-flammasome'

Nature Immunology volume 12, pages 379–380 (2011)Cite this article

Subjects

This article has been updated

The inflammasome has been linked to metabolic disorders such as obesity and type 2 diabetes. Data now suggest that the crosstalk between the inflammasome and autophagy critically mediates cytoplasmic receptor NLRP3–dependent activation of the inflammasome by the saturated fatty acids contained in a high-fat diet.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Involvement of the inflammasome in type 2 diabetes pathogenesis.

Change history

  • 11 July 2011

    In the version of this article initially published, author Augustine Choi lacked an additional affiliation. The correct affiliations should include College of Medicine, Kyung Hee University, Seoul, Korea. This has been corrected in the HTML and PDF versions of the article.

References

  1. Hotamisligil, G.S. Nature 444, 860–867 (2006).

    Article  CAS  Google Scholar 

  2. Schroder, K. & Tschopp, J. Cell 140, 821–832 (2010).

    Article  CAS  Google Scholar 

  3. Wen, H. et al. Nat. Immunol. 12, 408–415 (2011).

    Article  CAS  Google Scholar 

  4. Vandanmagsar, B. et al. Nat. Med. 17, 179–188 (2011).

    Article  CAS  Google Scholar 

  5. Larsen, C.M. et al. N. Engl. J. Med. 356, 1517–1526 (2007).

    Article  CAS  Google Scholar 

  6. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  Google Scholar 

  7. Masters, S.L. et al. Nat. Immunol. 11, 897–904 (2010).

    Article  CAS  Google Scholar 

  8. Stienstra, R. et al. Cell Metab. 12, 593–605 (2010).

    Article  CAS  Google Scholar 

  9. Nakahira, K. et al. Nat. Immunol. 12, 222–230 (2011).

    Article  CAS  Google Scholar 

  10. Lamkanfi, M. et al. J. Cell Biol. 187, 61–70 (2009).

    Article  CAS  Google Scholar 

  11. Levine, B., Mizushima, N. & Virgin, H.W. Nature 469, 323–335 (2011).

    Article  CAS  Google Scholar 

  12. Shaw, R.J. et al. Science 310, 1642–1646 (2005).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augustine M.K. Choi is in the Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA, and the College of Medicine, Kyung Hee University, Seoul, Korea.,

    Augustine M K Choi

  2. Kiichi Nakahira is in the Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.,

    Kiichi Nakahira

Authors
  1. Augustine M K Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiichi Nakahira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Augustine M K Choi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, A., Nakahira, K. Dampening insulin signaling by an NLRP3 'meta-flammasome'. Nat Immunol 12, 379–380 (2011). https://doi.org/10.1038/ni.2028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.2028

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing